logo

For the Inventor, By the Inventor

Essex, United Kingdom

Amanda Jane Van De Poël

USPTO Granted Patents = 15 

Average Co-Inventor Count = 12.0

ph-index = 5

Forward Citations = 118(Granted Patents)


Company Filing History:

goldMedal15 out of 1,501 
 
Astrazeneca Ab
 patents

Years Active: 2016-2024

Loading Chart...
15 patents (USPTO):Explore Patents
1. 12054465 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2024-08-06),
2. 11814359 - Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-11-14),
3. 11773069 - Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-10-03),
4. 11680049 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-20),
5. 11673872 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-13),
6. 11673871 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-13),
7. 11667615 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-06),
8. 11655224 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),
9. 11655223 - Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),
10. 11655222 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),
11. 11655221 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),
12. 11117874 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2021-09-14),
13. 10669245 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors (2020-06-02),
14. 10287258 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2019-05-14),
15. 9522894 - [object Object] (2016-12-20),

Title: **Inventor Amanda Jane Van De Poël: Pioneering Research in Respiratory Therapeutics**

Introduction

Amanda Jane Van De Poël, a notable inventor based in Essex, GB, has made significant contributions to the field of pharmaceutical science. With a total of 15 patents to her name, Amanda’s research focuses on innovative compounds that have the potential to treat various clinical conditions, particularly respiratory diseases.

Latest Patents

Among her most recent patents, Amanda has developed compounds such as certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides, which serve as dipeptidyl peptidase 1 inhibitors. These unique compounds aim to inhibit DPP1 activity, showcasing their utility in treating and preventing respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). Furthermore, her work includes the formulation of pharmaceutical compositions containing these compounds and the processes for their preparation.

Career Highlights

Amanda is currently employed at AstraZeneca AB, a prominent player in the global pharmaceuticals industry. Her tenure at this esteemed company underscores her commitment to advancing medical science through research and innovation. Through her expertise and dedication, she has positioned herself as a vital contributor to the development of new therapeutic options.

Collaborations

Throughout her career, Amanda has had the opportunity to collaborate with talented professionals, including her coworkers Stephen Connolly and Steven Swallow. These partnerships have enriched her research endeavors and have fostered an environment of shared knowledge and innovative solutions in the field of respiratory therapeutics.

Conclusion

In summary, Amanda Jane Van De Poël stands out as an influential inventor whose work is paving the way for new treatments in respiratory healthcare. With a strong portfolio of patents and a dedication to scientific advancement, she continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…